Home » Topics » Conferences

Conferences
RSS

AAAAI news: BM-144 as a new lead TxA2 antagonist molecule for asthma, thrombosis

March 7, 2000

Tyrosine kinase inhibitor D-58 is a potent antiallergic, antiinflammatory agent

March 7, 2000

European mutual recognition approval obtained for candesartan/HCTZ combination

March 7, 2000

In vitro and in vivo studies with specific chymase inhibitor suggest potential in atopic dermatitis

March 6, 2000

Rupatadine inhibits TNF-alpha release, may have potential in late-phase allergic reactions

March 6, 2000

Exploratory human studies with PNU-142731A reported at AAAAI meeting

March 6, 2000

Phase I/II trial examines multiple doses of IL-4R in asthmatic patients

March 6, 2000

AAAAI news: icatibant effective in reducing antigen-induced nasal hyperresponsiveness in SAR

March 6, 2000

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

March 3, 2000

Feasibility of HSV-TK/GCV gene therapy demonstrated in glioblastoma multiforme

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...